| N | % | Developed type 2 diabetes up to 31st March 2020 | ||
---|---|---|---|---|---|
N | % | ||||
Participants at the three providers with programmes of 13 sessions in length (n = 51,803) | |||||
 | All participants | 51,803 | 100% | 3530 | 6.8% |
Programme completion | Partial attendance (< 60% of sessions) | 25,015 | 48.3% | 2155 | 8.6% |
Completed programme (≥ 60% of sessions) | 26,788 | 51.7% | 1375 | 5.1% | |
Number of programme sessions attended | 1 session | 4391 | 8.5% | 415 | 9.5% |
2 sessions | 2976 | 5.7% | 285 | 9.6% | |
3 sessions | 3412 | 6.6% | 285 | 8.4% | |
4 sessions | 4238 | 8.2% | 385 | 9.1% | |
5 sessions | 3409 | 6.6% | 280 | 8.2% | |
6 sessions | 3347 | 6.5% | 280 | 8.4% | |
7 sessions | 3242 | 6.3% | 230 | 7.1% | |
8 sessions | 3216 | 6.2% | 215 | 6.7% | |
9 sessions | 3492 | 6.7% | 230 | 6.6% | |
10 sessions | 4231 | 8.2% | 240 | 5.7% | |
11 sessions | 5490 | 10.6% | 275 | 5.0% | |
12 sessions | 5847 | 11.3% | 235 | 4.0% | |
13 sessions | 4512 | 8.7% | 185 | 4.1% | |
Participants at all four providers (n = 66,010) | |||||
 | All participants | 66,010 | 100% | 4320 | 6.5% |
Programme completion | Partial attendance (< 60% of sessions) | 32,090 | 48.6% | 2645 | 8.2% |
Completed programme (≥ 60% of sessions) | 33,920 | 51.4% | 1675 | 4.9% |